title: Can we guarantee less nephrotoxicity when vancomycin is administered by continuous infusion?
authors.affiliation: Pharmacy Department, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Echeverría-Esnal
authors.affiliation: Pharmacy Department, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Mónica
authors.initials: M
authors.lastname: Marín-Casino
authors.affiliation: Pharmacy Department, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Retamero
authors.affiliation: Pharmacy Department, Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain; Infectious Diseases Research Group, IMIM (Institut Municipal d'Investigacions Biomèdiques), Barcelona, Spain. Electronic address: sgrau@parcdesalutmar.cat.
authors.forename: Santiago
authors.initials: S
authors.lastname: Grau
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D051437:Renal Insufficiency / Q000139:chemically induced*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin